Ko JJ - Search Results

1

Real-world evaluation of access-driven Canadian treatment sequences in progressive prostate cancer (REACTIVATE).

Ko JJ, Mbuagbaw L, Tyldesley S, Lowther J, Sunderland K, Royer C, Faure M, MacPhail C, Faizi S, Cheung WY, Lee-Ying R. Ko JJ, et al. Can Urol Assoc J. 2024 Mar 1. doi: 10.5489/cuaj.8620. Online ahead of print. Can Urol Assoc J. 2024. PMID: 38466865 Free article.

2

Real-world experience managing unresectable or metastatic small cell carcinoma of the prostate.

Ko JJ, Adams J, McMillan T, Sunderland K, Goulart J, Rauw J, Parimi S. Ko JJ, et al. Can Urol Assoc J. 2022 Nov;16(11):E528-E532. doi: 10.5489/cuaj.7802. Can Urol Assoc J. 2022. PMID: 35704939 Free PMC article.

3

Causes of mortality in older patients with stage 3 colon cancer.

Raycraft T, Cheung WY, Yin Y, Speers C, Ko JJ, Mariano C. Raycraft T, et al. Among authors: ko jj. J Geriatr Oncol. 2019 Jan;10(1):138-142. doi: 10.1016/j.jgo.2018.06.002. Epub 2018 Jun 28. J Geriatr Oncol. 2019. PMID: 29960748

4

Reasons for Underuse of Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer.

Ko JJ, Kennecke HF, Lim HJ, Renouf DJ, Gill S, Woods R, Speers C, Cheung WY. Ko JJ, et al. Clin Colorectal Cancer. 2016 Jun;15(2):179-85. doi: 10.1016/j.clcc.2015.09.002. Epub 2015 Sep 30. Clin Colorectal Cancer. 2016. PMID: 26520019

5

Genetic testing practices among specialist physicians who treat prostate cancer A Canadian, cross-sectional survey.

Yip SM, Morash C, Kolinsky MP, Kapoor A, Ong M, Selvarajah S, Nuk J, Compton K, Pouliot F, Lavallée LT, Khalaf DJ, Hamilton RJ, Gotto GT, Rendon RA, Antebi E, Hotte SJ, Malone S, Chi KN, Drachenberg DE, Saad F, Chan J, Ferrario C, Ko J, Shayegan B, Parimi S, So AI, Feifer A, Jansz K, Finch D, Chin JL, Osborne B, Ho KF, Galamo CD, Zardan A, Niazi T. Yip SM, et al. Can Urol Assoc J. 2023 Oct;17(10):326-336. doi: 10.5489/cuaj.8403. Can Urol Assoc J. 2023. PMID: 37494316 Free PMC article.

6

BeTTer Outcomes Workgroup Health Quality Initiative to optimize bone health for prostate cancer patients in the British Columbia Cancer System.

Noonan K, Ko JJ, Black PC, Peacock M, Finch D, Kollmannsberger C, Martins I, So AI, Pai HH. Noonan K, et al. Among authors: ko jj. Can Urol Assoc J. 2023 Aug 31;17(12):379-87. doi: 10.5489/cuaj.8477. Online ahead of print. Can Urol Assoc J. 2023. PMID: 37882539 Free PMC article.

7

Disease characteristics and survival outcomes of extragonadal primary germ cell tumour in two Canadian tertiary cancer centres.

Ko JJ, Asif T, Li H, Alimohamed N, Nguyen PT, Heng DY. Ko JJ, et al. Can Urol Assoc J. 2016 May-Jun;10(5-6):E165-E170. doi: 10.5489/cuaj.3357. Epub 2016 May 12. Can Urol Assoc J. 2016. PMID: 27790297 Free PMC article.

8

Patient, disease, and survival outcomes for stage IB to stage IV cervical cancer-A population study.

Wang C, Lester B, Huang L, Sun S, Ko JJ. Wang C, et al. Among authors: ko jj. Womens Health (Lond). 2023 Jan-Dec;19:17455057231164551. doi: 10.1177/17455057231164551. Womens Health (Lond). 2023. PMID: 37052298 Free PMC article.

9

Recent advances in circulating tumor cells and cell-free DNA in metastatic prostate cancer: a review.

Parimi S, Ko JJ. Parimi S, et al. Among authors: ko jj. Expert Rev Anticancer Ther. 2017 Oct;17(10):939-949. doi: 10.1080/14737140.2017.1359544. Epub 2017 Jul 31. Expert Rev Anticancer Ther. 2017. PMID: 28737470 Review.

10

Survival Outcomes Associated with First and Second-Line Palliative Systemic Therapies in Patients with Metastatic Bladder Cancer.

Beigi A, Vafaei-Nodeh S, Huang L, Sun SZ, Ko JJ. Beigi A, et al. Among authors: ko jj. Curr Oncol. 2021 Sep 29;28(5):3812-3824. doi: 10.3390/curroncol28050325. Curr Oncol. 2021. PMID: 34677243 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

176 results

Search Page